Accelerating Change Marks 2012 for Life Sciences
A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.
A Look Ahead at BioPharma Manufacturing and Regulation
FDA talks about the changing scope of regulatory science.
Epigenetics Drives Pharma Innovation
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.
A Look Ahead in Biomanufacturing
Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
Drug Quality at Center Stage for FDA and Manufacturers
Shortages spur efforts to overhaul manufacturing oversight.
Falsified Medicines Directive Takes Shape in Europe
The EU fine-tunes the Falsified Medicines Directive.
The Future of Biopharma
What the industry's future holds and what needs to be done to get there.
Report from Brazil
Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.
Aseptic Processing: A Primer
NIBRT's Ray O'Connor provides an overview of aseptic processing.
Biologics: What Does the Future Hold?
Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.
Polishing Complex Therapeutic Proteins
A new downstream purification platform using a salt-tolerant membrane adsorber.
The Future Quality Laboratory
A recent ISPE guidance provides a baseline for the design of quality laboratory facilities.
Bioconjugates: The Adaptable Challenge
Conjugation of a biologic to a carrier molecule can solve problems in solubility and stability, but introduces its own challenges.
Offshoring Biomanufacturing
Will international biomanufacturing outsourcing become mainstream in this decade?
BioPharm International, January 2013 Issue (PDF)
The Future of BioPharma Innovation
